Buscar
Congreso SOLACI

Búsqueda de: Ticagrelor

Si no está conforme con los resultados, inténtelo de nuevamente.
Antiplatelet

Antiplatelet Treatment with Ticagrelor vs. Clopidogrel in Patients with Chronic Coronary Syndrome

Achieving rapid and maximum inhibition of platelet aggregation can reduce complications related to scheduled percutaneous coronary intervention...
solaci -
Ir
Acute coronary syndromes

TCT 2023 | T-PASS TRIAL, ASA and Ticagrelor in Acute Coronary Syndrome

This is a multicenter randomized study including 2,850 patients with acute coronary syndrome. Patients were randomized to:...
solaci -
Ir
Acute coronary syndromes

Substudy TALOS AMI: from Ticagrelor to Clopidogrel in Patients with High Risk of Bleeding and AMI

The preference for the use of potent P2Y12 inhibitors such as ticagrelor and prasugrel in patients with...
solaci -
Ir
Antiplatelet

Ticagrelor or Prasugrel Post-PCI in Daily Practice Patients

The ISAR-REACT 5 showed a significant reduction in the composite outcome of death, acute myocardial infarction (AMI),...
solaci -
Ir
Antiplatelet

Safety and Efficacy of Ticagrelor Monotherapy According to BMI

Obesity is growing dramatically around the world, regardless of income. For instance, 53% of US adults are...
solaci -
Ir
Antiplatelet

Ticagrelor Monotherapy: Valid after 12 Months?

Recent studies on antiplatelet antiaggregation support the use of short dual antiaggregation therapy (DAPT), even in unforeseen...
solaci -
Ir
Antiplatelet

Ticagrelor Shows Benefits in Coronary Microvascular Function after NSTEMI

Coronary microvascular disfunction (CMD) is an important long-term prognosis predictor. CMD treatment can be an effective therapeutic...
solaci -
Ir
Acute coronary syndromes

REVERSE-IT | Bentracimab: Progress on the Antidote for Ticagrelor in Emergency Scenarios

Optimizing an antiplatelet therapy after an acute coronary syndrome (ACS) aims at reducing the major adverse cardiac...
solaci -
Ir

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Selecting Renal Denervation Responsive Patients: Meta-Analysis of Observational Data

solaci - 0
Hypertension treatment has evolved considerably over time. However, managing adverse events driven by medication is still challenging, as is low patient adherence, be it...

Myocardial Damage in MAC

solaci - 0
Mitral annulus calcification (MAC) affects between 8% and 23% of the population. It is more common in women and patients with renal insufficiency. This...

Initial Complete Revascularization vs. Staged Revascularization in Patients with STEMI and Multivessel Disease

solaci - 0
In patients with ST-segment elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (primary PCI), multivessel disease is observed in up to 40%...

Noticias Institucionales

National and Internacional Live Cases at the Next SOLACI-CACI 2024

solaci - 0
Discover all the live national and international cases at the upcoming SOLACI-CACI 2024 Congress. Scientific program Register now con descuentos   Live International Transmission Tribute to Alain Cribier...

Discover the international guests of the SOLACI-CACI 2024 Congress

solaci - 0
We are getting closer to the largest gathering of interventional cardiologists in Latin America. Discover the prestigious guests from Europe, Asia, and the United...

New Issue of SOLACI-LATAM Peripheral Registry in the European Medical Journal

solaci - 0
We are proud to announce that the Latin American Society of Interventional Cardiology is sharing their latest issue of SOLACI-LATAM Peripheral Registry in the...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad